TAZICEF

Product NDC: 0409-5084
11-digit product format: 004095084
Labeler code: 0409
Product ID: 0409-5084_ab9c6f3a-f684-4cc3-b870-1a06a748a1a2
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: CEFTAZIDIME
Dosage form: INJECTION, POWDER, FOR SOLUTION
Route: INTRAVENOUS
Labeler: Hospira, Inc.
Application: ANDA062662
Marketing category: ANDA
Marketing start: 2005-12-16
Substance: CEFTAZIDIME
Active strength: 2 g/1
Pharmacologic classes: Cephalosporin Antibacterial [EPC], Cephalosporins [CS]
NDC exclude flag: No
Listing certified through: 2027-12-31
Current FDA listing: Yes

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 3 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	0409-5084		D	Discontinued by firm	2026-08-03
excluded package	package	0409-5084	0409-5084-11	D	Discontinued by firm	2026-08-03
excluded package	package	0409-5084	0409-5084-51	D	Discontinued by firm	2026-08-03

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 36 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	0409-5084-11	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	0409-5084-51	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	0409-5084-11	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	0409-5084-51	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	0409-5084-11	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	0409-5084-51	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	0409-5084-11	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	0409-5084-51	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	0409-5084-11	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	0409-5084-51	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	0409-5084-11	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	0409-5084-51	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	0409-5084-11	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	0409-5084-51	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	0409-5084-11	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	0409-5084-51	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	0409-5084-11	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	0409-5084-51	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	0409-5084-11	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	0409-5084-51	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	0409-5084-11	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	0409-5084-51	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	0409-5084-11	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	0409-5084-51	`557ba5c1ecfa…`	`9c80585c8c6e…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 4 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	Approval date
A062662-001	TAZICEF	CEFTAZIDIME	500MG/VIAL	INJECTABLE / INJECTION		1986-03-06
A062662-002	TAZICEF	CEFTAZIDIME	1GM/VIAL	INJECTABLE / INJECTION	AP	1986-03-06
A062662-003	TAZICEF	CEFTAZIDIME	2GM/VIAL	INJECTABLE / INJECTION	AP	1986-03-06
A062662-004	TAZICEF	CEFTAZIDIME	6GM/VIAL	INJECTABLE / INJECTION	AP	1986-03-06

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 3 matching rows.

Application-product, TE code table
Application-product	TE code
A062662-002	AP
A062662-003	AP
A062662-004	AP

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 5 · 164 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A062662-001	TAZICEF	500MG/VIAL	INJECTABLE / INJECTION		1986-03-06	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A062662-002	TAZICEF	1GM/VIAL	INJECTABLE / INJECTION	AP	1986-03-06	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A062662-003	TAZICEF	2GM/VIAL	INJECTABLE / INJECTION	AP	1986-03-06	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A062662-004	TAZICEF	6GM/VIAL	INJECTABLE / INJECTION	AP	1986-03-06	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A062662-001	TAZICEF	500MG/VIAL	INJECTABLE / INJECTION		1986-03-06	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A062662-002	TAZICEF	1GM/VIAL	INJECTABLE / INJECTION	AP	1986-03-06	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A062662-003	TAZICEF	2GM/VIAL	INJECTABLE / INJECTION	AP	1986-03-06	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A062662-004	TAZICEF	6GM/VIAL	INJECTABLE / INJECTION	AP	1986-03-06	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A062662-001	TAZICEF	500MG/VIAL	INJECTABLE / INJECTION		1986-03-06	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A062662-002	TAZICEF	1GM/VIAL	INJECTABLE / INJECTION	AP	1986-03-06	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A062662-003	TAZICEF	2GM/VIAL	INJECTABLE / INJECTION	AP	1986-03-06	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A062662-004	TAZICEF	6GM/VIAL	INJECTABLE / INJECTION	AP	1986-03-06	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A062662-001	TAZICEF	500MG/VIAL	INJECTABLE / INJECTION		1986-03-06	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A062662-002	TAZICEF	1GM/VIAL	INJECTABLE / INJECTION	AP	1986-03-06	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A062662-003	TAZICEF	2GM/VIAL	INJECTABLE / INJECTION	AP	1986-03-06	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A062662-004	TAZICEF	6GM/VIAL	INJECTABLE / INJECTION	AP	1986-03-06	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A062662-001	TAZICEF	500MG/VIAL	INJECTABLE / INJECTION		1986-03-06	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A062662-002	TAZICEF	1GM/VIAL	INJECTABLE / INJECTION	AP	1986-03-06	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A062662-003	TAZICEF	2GM/VIAL	INJECTABLE / INJECTION	AP	1986-03-06	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A062662-004	TAZICEF	6GM/VIAL	INJECTABLE / INJECTION	AP	1986-03-06	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A062662-001	TAZICEF	500MG/VIAL	INJECTABLE / INJECTION		1986-03-06	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A062662-002	TAZICEF	1GM/VIAL	INJECTABLE / INJECTION	AP	1986-03-06	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A062662-003	TAZICEF	2GM/VIAL	INJECTABLE / INJECTION	AP	1986-03-06	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A062662-004	TAZICEF	6GM/VIAL	INJECTABLE / INJECTION	AP	1986-03-06	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A062662-001	TAZICEF	500MG/VIAL	INJECTABLE / INJECTION		1986-03-06	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A062662-002	TAZICEF	1GM/VIAL	INJECTABLE / INJECTION	AP	1986-03-06	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A062662-003	TAZICEF	2GM/VIAL	INJECTABLE / INJECTION	AP	1986-03-06	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A062662-004	TAZICEF	6GM/VIAL	INJECTABLE / INJECTION	AP	1986-03-06	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A062662-001	TAZICEF	500MG/VIAL	INJECTABLE / INJECTION		1986-03-06	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A062662-002	TAZICEF	1GM/VIAL	INJECTABLE / INJECTION	AP	1986-03-06	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A062662-003	TAZICEF	2GM/VIAL	INJECTABLE / INJECTION	AP	1986-03-06	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A062662-004	TAZICEF	6GM/VIAL	INJECTABLE / INJECTION	AP	1986-03-06	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A062662-001	TAZICEF	500MG/VIAL	INJECTABLE / INJECTION		1986-03-06	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A062662-002	TAZICEF	1GM/VIAL	INJECTABLE / INJECTION	AP	1986-03-06	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A062662-003	TAZICEF	2GM/VIAL	INJECTABLE / INJECTION	AP	1986-03-06	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A062662-004	TAZICEF	6GM/VIAL	INJECTABLE / INJECTION	AP	1986-03-06	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A062662-001	TAZICEF	500MG/VIAL	INJECTABLE / INJECTION		1986-03-06	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A062662-002	TAZICEF	1GM/VIAL	INJECTABLE / INJECTION	AP	1986-03-06	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A062662-003	TAZICEF	2GM/VIAL	INJECTABLE / INJECTION	AP	1986-03-06	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A062662-004	TAZICEF	6GM/VIAL	INJECTABLE / INJECTION	AP	1986-03-06	`d06236e962d9…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 4 · 142 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A062662-002	AP	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A062662-003	AP	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A062662-004	AP	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A062662-002	AP	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A062662-003	AP	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A062662-004	AP	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A062662-002	AP	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A062662-003	AP	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A062662-004	AP	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A062662-002	AP	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A062662-003	AP	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A062662-004	AP	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A062662-002	AP	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A062662-003	AP	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A062662-004	AP	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A062662-002	AP	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A062662-003	AP	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A062662-004	AP	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A062662-002	AP	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A062662-003	AP	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A062662-004	AP	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A062662-002	AP	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A062662-003	AP	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A062662-004	AP	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A062662-002	AP	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A062662-003	AP	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A062662-004	AP	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A062662-002	AP	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A062662-003	AP	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A062662-004	AP	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A062662-002	AP	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A062662-003	AP	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A062662-004	AP	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A062662-002	AP	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A062662-003	AP	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A062662-004	AP	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A062662-002	AP	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A062662-003	AP	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A062662-004	AP	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A062662-002	AP	1	`8072bd15b7f6…`

Additional Listing Data#

Finished product: Yes
Brand name base: TAZICEF
Listing expiration: 2027-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
CEFTAZIDIME	2 g/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
9M416Z9QNR	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 4 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
1659283	Internal RxNorm lookup
1659287	Internal RxNorm lookup
1659292	Internal RxNorm lookup
1659294	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
40d48c5d-650e-461b-a67b-7e65772d1b92	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
fb7d24f2-fcd1-4dc6-b9d0-b1f65bfffab5	Product name	1	20150409

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
0409-5084-11	TAZICEF	10 in 1 CARTON	INJECTION, POWDER, FOR SOLUTION	10		16
0409-5084-13	TAZICEF	1 in 1 VIAL, SINGLE-DOSE	INJECTION, POWDER, FOR SOLUTION	1		16

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
0409-5084-11	EA - Each	0409-5084	4464c09b-dcb5-48aa-ae07-9025bcfe8b87	1	2012-07-24
0409-5084-13	EA - Each	0409-5084	0333b2f2-c9ea-4408-aa50-4aad06872bfc	1	2019-09-05
0409-5084-51	EA - Each	0409-5084	8276c0fd-73f0-490c-96a2-461e55693e4f	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
CEFTAZIDIME	ACTIVE INGREDIENT	9M416Z9QNR	TAZICEF (CEFTAZIDIME) INJECTION, POWDER, FOR SOLUTION [HOSPIRA, INC.]	2
CEFTAZIDIME ANHYDROUS	ACTIVE MOIETY	DZR1ENT301	TAZICEF (CEFTAZIDIME) INJECTION, POWDER, FOR SOLUTION [HOSPIRA, INC.]	2
Sodium Carbonate	INACTIVE INGREDIENT	45P3261C7T	TAZICEF (CEFTAZIDIME) INJECTION, POWDER, FOR SOLUTION [HOSPIRA, INC.]	2

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
0409-5084	TAZICEF (CEFTAZIDIME) INJECTION, POWDER, FOR SOLUTION [HOSPIRA, INC.]	15	Current NDC, Legacy NDC, 2 package rows	20240508_40d48c5d-650e-461b-a67b-7e65772d1b92.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
TAZICEF	CEFTAZIDIME	Hospira, Inc.	40d48c5d-650e-461b-a67b-7e65772d1b92	2026-05-04	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 062662 application number: ANDA062662 ndc (product): 0409-5084
TAZICEF	CEFTAZIDIME	Hospira, Inc.	1ab5ae3e-e303-4499-4c89-472d7cc1e46c	2024-07-04	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 062662 application number: ANDA062662

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
9M416Z9QNR	CEFTAZIDIME	78439-06-2	CEFTAZIDIME

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
1659283	cefTAZidime 1 GM Injection	PSN	40d48c5d-650e-461b-a67b-7e65772d1b92	16
1659287	cefTAZidime 2 GM Injection	PSN	40d48c5d-650e-461b-a67b-7e65772d1b92	16
1659292	Tazicef 1 GM Injection	PSN	40d48c5d-650e-461b-a67b-7e65772d1b92	16
1659294	Tazicef 2 GM Injection	PSN	40d48c5d-650e-461b-a67b-7e65772d1b92	16
1659292	ceftazidime 1000 MG Injection [Tazicef]	SBD	40d48c5d-650e-461b-a67b-7e65772d1b92	16
1659294	ceftazidime 2000 MG Injection [Tazicef]	SBD	40d48c5d-650e-461b-a67b-7e65772d1b92	16
1659283	ceftazidime 1000 MG Injection	SCD	40d48c5d-650e-461b-a67b-7e65772d1b92	16
1659287	ceftazidime 2000 MG Injection	SCD	40d48c5d-650e-461b-a67b-7e65772d1b92	16
1659283	ceftazidime (as ceftazidime pentahydrate) 1000 MG Injection	SY	40d48c5d-650e-461b-a67b-7e65772d1b92	16
1659287	ceftazidime (as ceftazidime pentahydrate) 2000 MG Injection	SY	40d48c5d-650e-461b-a67b-7e65772d1b92	16
1659283	ceftazidime 1 GM Injection	SY	40d48c5d-650e-461b-a67b-7e65772d1b92	16
1659287	ceftazidime 2 GM Injection	SY	40d48c5d-650e-461b-a67b-7e65772d1b92	16
1659292	Tazicef 1000 MG Injection	SY	40d48c5d-650e-461b-a67b-7e65772d1b92	16
1659294	Tazicef 2000 MG Injection	SY	40d48c5d-650e-461b-a67b-7e65772d1b92	16

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Marketing end	Sample	Exclude flag	Status
0409-5084-11	00409508411	10 VIAL, SINGLE-DOSE in 1 CARTON (0409-5084-11) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (0409-5084-13)	2005-12-16	0000-00-00	No	No	Current
0409-5084-13	00409508413	1 in 1 VIAL, SINGLE-DOSE					Historical